Safety analysis of Off-Label Intravitreal Bevacizumab in the FDA Adverse Event Reporting System (FAERS) Database

Zenodo (CERN European Organization for Nuclear Research) 2026 Open access

Read full text
Authors: Homero Contreras-Salinas, Sebastian Quirarte-Justo
DOI: 10.5281/zenodo.18246513
Cited by: 0

Abstract

Supplementary Material for "Safety analysis of Off-Label Intravitreal Bevacizumab in the FDA Adverse Event Reporting System (FAERS) Database".

Fields of Study & Subjects

Pharmacovigilance and Adverse Drug Reactions Drug-Induced Ocular Toxicity Retinal Diseases and Treatments

Publication details

Journal / source
Zenodo (CERN European Organization for Nuclear Research)
Publication date
1 January 2026
Language
EN